Dec 10, 2019 / 02:10PM GMT
Alexander Blostein - Goldman Sachs Group Inc., Research Division - Lead Capital Markets Analyst
Great. So we're going to get started. Next, I would like to welcome management team from CME. With us today are John Pietrowicz, the company's CFO; and Sean Tully, Global Head of Financial and OTC Products. CME is wrapping up another strong year with volumes on track to exceed last year's record at about 19.5 million shares traded a day -- or million contracts, rather, traded daily, not shares. The firm has also been obviously very busy integrating the acquisition of NEX Group, which closed up a year ago, actually right around this time last year. So we look forward to getting an update on both the business and how the integration is coming along both from you.
John William Pietrowicz - CME Group Inc. - Senior MD & CFO
Thank you. Thank you, and good morning, everyone.
Questions and Answers:
Alexander Blostein - Goldman Sachs Group Inc., Research Division - Lead Capital Markets AnalystGreat. So the first kind of
Trustpilot
